Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abbreviated R-CHOP in completely excised Stage I/II DLBCL
NCT01279902Phase 2Unknown
- Sponsor
- Asan Medical Center
- Start
- Aug 2010
- Primary completion
- Aug 2016
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of rituximab in diffuse large B-cell lymphoma (DLBCL), sponsored by Asan Medical Center. Status: unknown.
02
Drugs
rituximab
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT01279902.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01279902.